Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis / 中华男科学杂志
National Journal of Andrology
;
(12): 48-50, 2002.
Artículo
en Chino
| WPRIM
| ID: wpr-287206
ABSTRACT
<p><b>OBJECTIVES</b>To evaluate a new effective treatment for prostatodynia (PD) and chronic non-bacterial prostatitis (CNP).</p><p><b>METHODS</b>One hundred and thirty-six patients suffered from PD or CNP were divided randomly into experiment group (n = 76), which were treated with external RF hyperthermia (ERFH) combining with alpha 1-adrenergic receptor blocker Terazosin for 12 weeks, and control group (n = 60), which were only treated with ERFH. Symptoms scores, urodynamic indexes and expressed prostate secretion were recorded pre- and post-treatments.</p><p><b>RESULTS</b>MFR and AFR were significantly improved and symptoms scores significantly decreased in both groups (P < 0.05). The efficacy was better in experiment group than that in control group. The combination treatment also led to a significantly decrease in MUP and MUCP (P < 0.05). Additionally, the leucocytes in expressed prostate secretion were also reduced in experiment group (P < 0.05).</p><p><b>CONCLUSIONS</b>Treatment of ERFH combining with alpha 1-adrenergic receptor blocker for patients with PD or CNP was effective and had little side-effect, while the future curative effect should be observed furtherly.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Dolor
/
Prostatitis
/
Terapéutica
/
Prazosina
/
Enfermedad Crónica
/
Terapia Combinada
/
Antagonistas Adrenérgicos alfa
/
Usos Terapéuticos
/
Quimioterapia
/
Antagonistas de Receptores Adrenérgicos alfa 1
Límite:
Adulto
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2002
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS